Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Factsheet
January 05, 2016
Q2 Solutions Comprehensive Cancer Panel
Targeted sequencing assay
The Q2 Solutions Comprehensive Cancer Panel is a targeted sequencing assay for analysis of genomic variation predictive of response to therapies in clinical development.
Systematic Design and Development of the Q2 Solutions Comprehensive Cancer Panel

A Case Study in Iterative Design and Validation

Personalizing oncology with genomics

Next-generation sequencing will transform oncology clinical trials and treatments for cancer.

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Read More